Ocular Hypertension Treatment Market to Grow with a CAGR of 3.82% through 2030
Rising
advancements
in treatment modalities are expected to drive the Global Ocular Hypertension
Treatment Market growth in the forecast period, 2026-2030
According to TechSci Research report, “Ocular
Hypertension Treatment Market – Global Industry Size, Share,
Trends, Competition Forecast & Opportunities, 2030F”, the Global Ocular
Hypertension Treatment Market stood at USD 3.67 billion in 2024 and is
anticipated to grow with a CAGR of 3.82% in the forecast period, 2025-2030. The
Global Ocular Hypertension Treatment Market is experiencing remarkable growth,
driven by a confluence of factors that are reshaping the landscape of ocular
healthcare. Ocular hypertension, characterized by elevated intraocular
pressure, poses a significant risk factor for glaucoma, a leading cause of
irreversible blindness worldwide.
One
of the primary drivers behind the growth of the ocular hypertension treatment
market is the aging global population. As individuals age, the risk of
developing ocular hypertension and subsequent glaucoma increases. The elderly
are particularly vulnerable to these conditions due to changes in the eye's
drainage system, which can impede the flow of aqueous humor and lead to
elevated intraocular pressure. Changing lifestyle patterns and the prevalence
of digital devices are contributing significantly to the rise in ocular
hypertension cases. Prolonged screen time, extensive use of smartphones and
computers, and increased exposure to artificial lighting can strain the eyes,
potentially leading to ocular hypertension. As individuals of all ages spend
more time engaged with screens, the demand for ocular hypertension treatments,
including eye drops and preventive measures, has surged. Lifestyle factors are
thus acting as a driving force behind the market's expansion.
The ocular hypertension treatment market has witnessed
a notable transformation with the introduction of innovative therapeutic
options. While eye drops and oral medications have traditionally been the
mainstay of treatment, advancements in surgical techniques have expanded the
treatment landscape. Micro-invasive glaucoma surgery (MIGS) is a prime example
of this evolution. MIGS procedures are less invasive than traditional glaucoma
surgeries and offer a more effective approach to managing intraocular pressure.
These minimally invasive techniques have gained popularity among both patients
and clinicians, enhancing the market's growth prospects.
Browse over XX market data Figures spread
through XX Pages and an in-depth TOC on "Global Ocular
Hypertension Treatment Market.”
The Global Ocular Hypertension Treatment Market is
segmented into type, route of administration, distribution channel, regional distribution, and company.
Based on the Distribution Channel, the
Retail Pharmacy segment emerged as the dominant player in the market for
Global Ocular Hypertension Treatment Market in 2024. Retail pharmacies are
widespread and easily accessible, offering a physical presence in local
communities and healthcare facilities. Patients with ocular hypertension can
visit these pharmacies conveniently to purchase prescribed eye drops or
medications, making it a preferred choice for many individuals, especially
older patients who may be less familiar with online options. Retail pharmacies
provide the opportunity for patients to consult with pharmacists, who can offer
guidance and answer questions about ocular hypertension medications.
Major companies operating in Global Ocular
Hypertension Treatment Market are:
- Angelini Spa
- Laboratorios Sophia
- Neurim Pharmaceuticals Ltd
- Nicox SA
- Novartis AG.
- Aerie Pharmaceuticals, Inc.
- Abbvie, Inc
- Angelini Pharma S.p.a.
- Chong Kun Dang pharmaceutical Corp
- Lee Pharma Ltd
Download
Free Sample Report
Customers can also request for 10%
free customization on this report.
"The Global
Ocular Hypertension Treatment Market is poised for substantial growth in the
coming years. This optimism is fueled by a convergence of factors that are
reshaping the landscape of ocular healthcare. Rising awareness about ocular
health, coupled with increased access to advanced diagnostic tools, is expected
to lead to early detection and intervention for ocular hypertension, preventing
its progression to glaucoma. Pharmaceutical innovations, including more patient-friendly eye drops and sustained-release medications, are improving treatment adherence and efficacy. Minimally invasive surgical techniques, such as Micro-Invasive Glaucoma Surgery (MIGS), are gaining prominence for their superior safety profiles and quicker recovery times. Additionally, the expansion of telemedicine and remote monitoring is enhancing accessibility to
ocular care, particularly in underserved regions”, said Mr. Karan Chechi,
Research Director of TechSci Research, a research-based management consulting
firm.
“Ocular Hypertension Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Intraocular Hypertension, Glaucoma), By Route Of Administration (Oral, Parenteral, Other), By Distribution Channel (Retail Pharmacy, Online Pharmacy, Other), By Region and Competition 2020-2030F”, has evaluated the future growth potential of Global
Ocular Hypertension Treatment Market and provides statistics & information
on market size, structure and future market growth. The report intends to
provide cutting-edge market intelligence and help decision makers take sound
investment decisions. Besides, the report also identifies and analyzes the
emerging trends along with essential drivers, challenges, and opportunities in
Global Ocular Hypertension Treatment Market.
Contact
TechSci
Research LLC
420
Lexington Avenue, Suite 300,
New
York, United States- 10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com